Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | BCL2 | P10415 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29387158 | 1.00 | HDAC8 (0.43) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL30054627 | 0.98 | HDAC8 (0.42) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL1325535 | 0.92 | — | — | |
| SCHEMBL29399791 | 0.92 | — | — | |
| SCHEMBL23581841 | 0.90 | HDAC8 (0.36) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL1678456 | 0.90 | HDAC8 (0.48) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL5403801 | 0.85 | HDAC8 (0.41) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL29475405 | 0.84 | HDAC8 (0.43) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL28530462 | 0.83 | MEN1 (0.32) | HDAC8KDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL3455039 | 0.82 | HDAC8 (0.38) | HDAC8KDM4ESMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 836 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12508321-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-30 | — | — | US | claimed |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| US-20250162992-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-05-22 | — | — | US | claimed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| EP-3774786-B1 | METHOD FOR THE PREPARATION OF A 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONE | BAYER AG (DE) | 2024-12-25 | — | — | EP | claimed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-11779663-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-10-10 | — | — | US | claimed |
| CN-111094281-B | Chemical process for preparing monolactam antibiotics and intermediates thereof | 诺华股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-20230241241-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-08-03 | — | — | US | claimed |
| WO-2019026004-A2 | CHEMICAL PROCESS FOR MANUFACTURING MONOBACTAM ANTIBIOTIC AND INTERMEDIATES THEREOF | NOVARTIS AG (CH) | 2019-02-07 | — | — | WO | claimed |
| EP-3411074-A2 | SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF | Suzhou M-conj Biotech Co., Ltd. (CN) | 2018-12-12 | — | — | EP | claimed |
| WO-2018185526-A1 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2018-10-11 | — | — | WO | claimed |
| EP-3317246-A2 | SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | Suzhou M-conj Biotech Co., Ltd. (CN) | 2018-05-09 | — | — | EP | claimed |
| US-9839687-B2 | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule | SUZHOU M-CONJ BIOTECH CO., LTD. (CN) | 2017-12-12 | — | — | US | claimed |
| US-20150322155-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | Sushou M-conj Biotech Co., Ltd (CN) | 2015-11-12 | — | — | US | claimed |
| EP-1897901-B1 | BIODEGRADABLE POLYMER, PRODUCTION METHOD THEREOF, MOLDED PRODUCT THEREOF, AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2015-03-11 | — | — | EP | claimed |
| US-20090142982-A1 | Biodegradable Polymer, Production Method Thereof, Molded Product Thereof, and Use Thereof | MITSUI CHEMICALS INC. (JP) | 2009-06-04 | — | — | US | claimed |
| US-20080221303-A1 | Method for the Preparation of Peptide-Oligonucleotide Conjugates | FRUTAROM LTD. (IL) | 2008-09-11 | — | — | US | claimed |
| EP-1897901-A1 | BIODEGRADABLE POLYMER, PRODUCTION METHOD THEREOF, MOLDED PRODUCT THEREOF, AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2008-03-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12508321-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD4, CD2, B2M | HDAC8 2824/4885KDM4E 1062/4885SMN1; SMN2 4564/4885 |
| US-20250162992-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | NAAA, NCAPH, NCAPD2 | HDAC8 130/4885KDM4E 2937/4885SMN1; SMN2 3048/4885 |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | HDAC8 739/4885KDM4E 3062/4885SMN1; SMN2 4501/4885 |
| US-20080221303-A1 | Method for the Preparation of Peptide-Oligonucleotide Conjugates | VIP, PTMS, SSTR4 | HDAC8 3690/4885KDM4E 4496/4885SMN1; SMN2 2722/4885 |
| US-20150322155-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | DCLRE1A, AADAC, UACA | HDAC8 576/4885KDM4E 3428/4885SMN1; SMN2 4698/4885 |
| US-11779663-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | SLC25A1, GCDH, FH | HDAC8 868/4885KDM4E 2368/4885SMN1; SMN2 3078/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | HDAC8 293/4885KDM4E 4218/4885SMN1; SMN2 4051/4885 |
| US-20230241241-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | CD4, DCLRE1A, TOP1 | HDAC8 4284/4885KDM4E 4137/4885SMN1; SMN2 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.